Search research articles
Contact Us
Filters
Showing results (1-10 of 36) with videos related to
Page
of 4
Sort By:
Uirusu
|
January 1, 2015
Advances in drug development for hepatitis C
Tetsuro Suzuki, Kenji Nakashima, Takeshi Chida, et al.
Scientific Reports
|
November 19, 2016
LUC7L3/CROP inhibits replication of hepatitis B virus via suppressing enhancer II/basal core promoter activity
Yuan Li, Masahiko Ito, Suofeng Sun, et al.
Journal of Hepato-Biliary-Pancreatic Sciences
|
October 6, 2018
Clinical characteristics and risk factors for stent-stone complex formation following biliary plastic stent placement in patients with common bile duct stones
Junichi Kaneko, Kazuhito Kawata, Shinya Watanabe, et al.
Free Radical Biology & Medicine
|
December 16, 2023
Impact of amino acid substitutions in hepatitis C virus core region on the severe oxidative stress
Takeshi Chida, Shinya Watanabe, Kazuyoshi Ohta, et al.
Molecular Biology Reports
|
December 25, 2024
Elevated serum neprilysin levels in patients with chronic hepatitis C and metabolic dysfunction-associated steatotic liver disease: hepatic oxidative stress as an underlying mechanism
Kensuke Kitsugi, Takeshi Chida, Tomohiko Hanaoka, et al.
ISRN Hepatology
|
June 24, 2016
Improved Serum Alpha-Fetoprotein Levels after Iron Reduction Therapy in HCV Patients
Hidenao Noritake, Yoshimasa Kobayashi, Yukimasa Ooba, et al.
Nihon Shokakibyo Gakkai Zasshi = the Japanese Journal of Gastro-Enterology
|
November 8, 2017
[Spontaneous regression of pancreatic arteriovenous malformation under the influence of severe acute pancreatitis: a case report]
Maho Nagasawa, Kazuhito Kawata, Satoru Yamazaki, et al.
Internal Medicine (Tokyo, Japan)
|
March 10, 2015
Long-term pegylated interferon monotherapy following 72 weeks of pegylated interferon and ribavirin in hepatitis C virus genotype-1-infected slow responders
Shinya Watanabe, Yoshimasa Kobayashi, Kazuhito Kawata, et al.
Diseases (Basel, Switzerland)
|
October 28, 2025
C-Reactive Protein Levels Predict Improvement in the Liver Functional Reserve by Long-Term Rifaximin Treatment
Kensuke Kitsugi, Kazuhito Kawata, Go Murohisa, et al.
Antiviral Research
|
November 22, 2023
SRPKIN-1 as an inhibitor against hepatitis B virus blocking the viral particle formation and the early step of the viral infection
Xiaofang Li, Kenji Nakashima, Masahiko Ito, et al.
Page
of 4
Search research articles
Search
Showing results (1-10 of 36) with videos related to
Sort By:
Page
of 4
Uirusu
|
January 1, 2015
Advances in drug development for hepatitis C
Tetsuro Suzuki, Kenji Nakashima, Takeshi Chida, et al.
Scientific Reports
|
November 19, 2016
LUC7L3/CROP inhibits replication of hepatitis B virus via suppressing enhancer II/basal core promoter activity
Yuan Li, Masahiko Ito, Suofeng Sun, et al.
Journal of Hepato-Biliary-Pancreatic Sciences
|
October 6, 2018
Clinical characteristics and risk factors for stent-stone complex formation following biliary plastic stent placement in patients with common bile duct stones
Junichi Kaneko, Kazuhito Kawata, Shinya Watanabe, et al.
Free Radical Biology & Medicine
|
December 16, 2023
Impact of amino acid substitutions in hepatitis C virus core region on the severe oxidative stress
Takeshi Chida, Shinya Watanabe, Kazuyoshi Ohta, et al.
Molecular Biology Reports
|
December 25, 2024
Elevated serum neprilysin levels in patients with chronic hepatitis C and metabolic dysfunction-associated steatotic liver disease: hepatic oxidative stress as an underlying mechanism
Kensuke Kitsugi, Takeshi Chida, Tomohiko Hanaoka, et al.
ISRN Hepatology
|
June 24, 2016
Improved Serum Alpha-Fetoprotein Levels after Iron Reduction Therapy in HCV Patients
Hidenao Noritake, Yoshimasa Kobayashi, Yukimasa Ooba, et al.
Nihon Shokakibyo Gakkai Zasshi = the Japanese Journal of Gastro-Enterology
|
November 8, 2017
[Spontaneous regression of pancreatic arteriovenous malformation under the influence of severe acute pancreatitis: a case report]
Maho Nagasawa, Kazuhito Kawata, Satoru Yamazaki, et al.
Internal Medicine (Tokyo, Japan)
|
March 10, 2015
Long-term pegylated interferon monotherapy following 72 weeks of pegylated interferon and ribavirin in hepatitis C virus genotype-1-infected slow responders
Shinya Watanabe, Yoshimasa Kobayashi, Kazuhito Kawata, et al.
Diseases (Basel, Switzerland)
|
October 28, 2025
C-Reactive Protein Levels Predict Improvement in the Liver Functional Reserve by Long-Term Rifaximin Treatment
Kensuke Kitsugi, Kazuhito Kawata, Go Murohisa, et al.
Antiviral Research
|
November 22, 2023
SRPKIN-1 as an inhibitor against hepatitis B virus blocking the viral particle formation and the early step of the viral infection
Xiaofang Li, Kenji Nakashima, Masahiko Ito, et al.
Page
of 4